Novel erythropoiesis stimulating protein (NESP) for the treatment of anaemia of chronic disease associated with cancer

Anaemia is a common haematologic disorder in patients with cancer and has a multifactorial aetiology, including the effects of the malignancy itself and residual effects from previous therapy. Novel erythropoiesis stimulating protein (NESP, darbepoetin alfa), a protein with additional sialic acid co...

Descripción completa

Detalles Bibliográficos
Autores principales: Smith, R E, Jaiyesimi, I A, Meza, L A, Tchekmedyian, N S, Chan, D, Griffith, H, Brosman, S, Bukowski, R, Murdoch, M, Rarick, M, Saven, A, Colowick, A B, Fleishman, A, Gayko, U, Glaspy, J
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 2001
Materias:
Regular Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2363901/
https://www.ncbi.nlm.nih.gov/pubmed/11308271
http://dx.doi.org/10.1054/bjoc.2001.1749

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2363901/
https://www.ncbi.nlm.nih.gov/pubmed/11308271
http://dx.doi.org/10.1054/bjoc.2001.1749

Ejemplares similares